Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 3 6Phase 2/3 3Phase NA 1Phase 4 1Phase 1/2 1Phase 1 1

Status

Unknown 2Recruiting 2Completed 2

Sponsor Class

OTHER 182INDUSTRY 147NETWORK 13NIH 11OTHER_GOV 6UNKNOWN 2

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 3Gastrointestinal 2NET 1Endocrine 1

Conditions

Breast Neoplasms 3Stomach Neoplasms 1Rectal Neoplasms 1Neuroendocrine Tumors 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

Radiotherapy 10Cisplatin 9Carboplatin 7Capecitabine 6Neoadjuvant Therapy 5Gemcitabine 5Fluorouracil 5Docetaxel 5Paclitaxel 4Cyclophosphamide 4Trastuzumab 3Tamoxifen 3Surgical Procedures, Operative 3Oxaliplatin 3Hydralazine 3Etoposide 3Drug Therapy 3pertuzumab 2pegylated granulocyte colony-stimulating factor 2palbociclib 2endostar protein 2Valproic Acid 2Tranexamic Acid 2Temozolomide 2TP protocol 2Saline Solution 2Radiotherapy, Adjuvant 2Radiation 2Proton Pump Inhibitors 2Pemetrexed 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × OTHER_GOV × Capecitabine × Clear all
NCT07467330 2026-03-12

Dalpiciclib Combined With Endocrine Therapy and Metronomic Capecitabine vs Dalpiciclib Combined With Endocrine Therapy for First-line Treatment

Fujian Cancer Hospital

Phase 3 Recruiting
258 enrolled
Breast

Breast Neoplasms

NCT07185672 2025-09-22

PReCedeNT

Tata Memorial Hospital

Phase 3 Recruiting
162 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT00070213 2021-09-27

Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Medical Research Council

Phase 3 Completed
460 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT04351867 2020-07-16

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

Henan Cancer Hospital

Phase 3 Unknown
196 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01501669 2012-07-18

PROCEED

National Cancer Center, Korea

Phase 3 Unknown
222 enrolled
Breast

Breast Neoplasms

NCT00352378 2011-06-27

Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer

National Cancer Center, Korea

Phase 3 Completed
209 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡